Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series

BMC Infectious Diseases
Robert SlingerBaldwin Toye

Abstract

Salmonella spp. with reduced susceptibility to fluoroquinolones have higher than usual MICs to these agents but are still considered "susceptible" by NCCLS criteria. Delayed treatment response to fluoroquinolones has been noted, especially in cases of enteric fever due to such strains. We reviewed the ciprofloxacin susceptibility and clinical outcome of our recent enteric fever cases. Salmonella enterica Serotype Typhi (S. Typhi) and Serotype Paratyphi (S. Paratyphi) blood culture isolates (1998-2002) were tested against nalidixic acid by disk diffusion (DD) and agar dilution (AD) and to ciprofloxacin by AD using NCCLS methods and interpretive criteria. Reduced fluoroquinolone susceptibility was defined as a ciprofloxacin MIC of 0.125-1.0 mg/L. The clinical records of patients treated with ciprofloxacin for isolates with reduced fluoroquinolone susceptibility were reviewed. Seven of 21 (33%) S. Typhi and S. Paratyphi isolates had reduced susceptibility to fluoroquinolones (MIC range 0.125-0.5 mg/L). All 7 were nalidixic acid resistant by DD (no zone) and by AD (MIC 128- >512 mg/L). The other 14 isolates were nalidixic acid susceptible and fully susceptible to ciprofloxacin (MIC range 0.015-0.03 mg/L). Five of the 7 cases were t...Continue Reading

References

Apr 1, 1996·Antimicrobial Agents and Chemotherapy·D J GriggsL J Piddock
Feb 7, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J WainC M Parry
Jun 11, 1998·Emerging Infectious Diseases·M D HamptonE J Threlfall
Nov 29, 2002·The New England Journal of Medicine·Christopher M ParryJeremy J Farrar
Jun 28, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John A CrumpFrederick J Angulo
Sep 27, 2003·International Journal of Antimicrobial Agents·John G Gums
Feb 20, 2004·The Journal of Antimicrobial Chemotherapy·Pauliina KärpänojaHannu Sarkkinen

❮ Previous
Next ❯

Citations

Apr 10, 2009·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S HumeJ Torresi
Apr 24, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R-J HassingP J van Genderen
Apr 6, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ashish P MaskeyBuddha Basnyat
Apr 22, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sundeep K GuptaEric D Mintz
Aug 21, 2008·Foodborne Pathogens and Disease·Peter Gerner-Smidt, Jean M Whichard
Jul 4, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Romney M HumphriesJanet A Hindler
Nov 14, 2012·Antimicrobial Agents and Chemotherapy·Marcus Ho Yin Wong, Sheng Chen
Jan 24, 2008·Antimicrobial Agents and Chemotherapy·John A CrumpUNKNOWN Emerging Infections Program FoodNet and NARMS Working Groups
Jun 6, 2009·BMJ : British Medical Journal·Durrane ThaverZulfiqar A Bhutta
Jul 6, 2007·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Tom A Szakacs, Anne E McCarthy
Nov 14, 2008·Journal of Travel Medicine·Emanuele PontaliGiovanni Cassola
Jul 17, 2008·Journal of Medical Microbiology·Tamilarasu KadhiravanAnoop Misra
Aug 3, 2007·International Journal of Antimicrobial Agents·Miles Denton
Sep 27, 2005·The Lancet Infectious Diseases·Bradley A Connor, Eli Schwartz
Apr 10, 2017·Annals of Clinical Microbiology and Antimicrobials·Pinyo RattanaumpawanUNKNOWN CDC prevention epicenters program

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.